Sungpil Yoon

3.5k total citations
91 papers, 2.7k citations indexed

About

Sungpil Yoon is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Sungpil Yoon has authored 91 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 41 papers in Molecular Biology and 13 papers in Cancer Research. Recurrent topics in Sungpil Yoon's work include Drug Transport and Resistance Mechanisms (19 papers), Cytokine Signaling Pathways and Interactions (7 papers) and Cancer therapeutics and mechanisms (7 papers). Sungpil Yoon is often cited by papers focused on Drug Transport and Resistance Mechanisms (19 papers), Cytokine Signaling Pathways and Interactions (7 papers) and Cancer therapeutics and mechanisms (7 papers). Sungpil Yoon collaborates with scholars based in South Korea, United States and Canada. Sungpil Yoon's co-authors include Hyung Sik Kim, Ju-Hwa Kim, Alan G. Hinnebusch, Hongfang Qiu, Han Sung Kang, Ae‐Ran Choi, Mark J. Swanson, Jungsil Ro, Jee H. Jung and Byoung Jin Suh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Applied Physics Letters and Journal of Applied Physics.

In The Last Decade

Sungpil Yoon

90 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sungpil Yoon South Korea 29 1.4k 710 320 313 252 91 2.7k
Engı̇n Ulukaya Türkiye 37 1.4k 1.0× 1.6k 2.2× 253 0.8× 288 0.9× 418 1.7× 181 4.2k
Huanjie Yang China 32 2.0k 1.5× 721 1.0× 505 1.6× 293 0.9× 331 1.3× 57 3.8k
Steven A. Akman United States 40 2.5k 1.8× 827 1.2× 593 1.9× 277 0.9× 123 0.5× 108 4.3k
Marco Cordani Spain 26 1.1k 0.8× 486 0.7× 459 1.4× 709 2.3× 400 1.6× 72 3.0k
Lin Yang China 28 1.6k 1.1× 340 0.5× 201 0.6× 196 0.6× 283 1.1× 96 3.0k
Howard R. Mellor United Kingdom 26 1.3k 1.0× 862 1.2× 273 0.9× 159 0.5× 515 2.0× 35 2.8k
Zhigang Tu China 23 1.0k 0.7× 255 0.4× 294 0.9× 229 0.7× 97 0.4× 72 2.0k
Yan‐Ming Xu China 29 1.6k 1.2× 368 0.5× 314 1.0× 169 0.5× 143 0.6× 140 2.9k
Haolu Wang Australia 30 1.1k 0.8× 382 0.5× 297 0.9× 543 1.7× 213 0.8× 67 3.5k
Chanakya Nath Kundu India 38 2.1k 1.6× 990 1.4× 436 1.4× 320 1.0× 230 0.9× 124 4.1k

Countries citing papers authored by Sungpil Yoon

Since Specialization
Citations

This map shows the geographic impact of Sungpil Yoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sungpil Yoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sungpil Yoon more than expected).

Fields of papers citing papers by Sungpil Yoon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sungpil Yoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sungpil Yoon. The network helps show where Sungpil Yoon may publish in the future.

Co-authorship network of co-authors of Sungpil Yoon

This figure shows the co-authorship network connecting the top 25 collaborators of Sungpil Yoon. A scholar is included among the top collaborators of Sungpil Yoon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sungpil Yoon. Sungpil Yoon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Hyung Sik, et al.. (2024). Co-treatment With Aripiprazole and Vincristine Sensitizes P-Glycoprotein-Overexpressing Drug-resistant MCF-7/ADR Breast Cancer Cells. Anticancer Research. 44(3). 1051–1062. 3 indexed citations
2.
Sharma, Swati, et al.. (2023). Low-dose Pimecrolimus, an FDA-approved Calcineurin Inhibitor, Sensitizes Drug-resistant Cancer CellsviaStrong P-gp Inhibition. Anticancer Research. 43(3). 1103–1112. 3 indexed citations
3.
Kundu, Amit, Swati Sharma, Sam Kacew, et al.. (2023). Dendropanoxide Alleviates Thioacetamide-induced Hepatic Fibrosis via Inhibition of ROS Production and Inflammation in BALB/C Mice. International Journal of Biological Sciences. 19(9). 2630–2647. 16 indexed citations
4.
Kim, Hae-Ri, Jae Hyeon Park, Seung Jun Kwack, et al.. (2021). Using intracellular metabolic profiling to identify novel biomarkers of cisplatin-induced acute kidney injury in NRK-52E cells. Journal of Toxicology and Environmental Health. 85(1). 29–42. 7 indexed citations
5.
Lee, Su Hyun, Jae Hyeon Park, Jin-Sol Lee, et al.. (2021). A Low Dose of Aripiprazole Has the Strongest Sensitization Effect Among 19 Repositioned Bipolar Drugs in P-gp-overexpressing Drug-resistant Cancer Cells. Anticancer Research. 41(2). 687–697. 18 indexed citations
6.
Kim, Ji Yeong, et al.. (2018). Low Doses of the Anti-psychotic Drug Aripiprazole Have Strong P-gp-inhibitory Activity and Sensitize Anti-mitotic Drug-resistant Cancer Cells. Anticancer Research. 38(9). 5101–5108. 20 indexed citations
7.
Kim, Ji Yeong, Ji Yeon Son, Byung‐Mu Lee, Hyung Sik Kim, & Sungpil Yoon. (2018). Aging-related Repositioned Drugs, Donepezil and Sildenafil Citrate, Increase Apoptosis of Anti-mitotic Drug-resistant KBV20C Cells Through Different Molecular Mechanisms. Anticancer Research. 38(9). 5149–5157. 16 indexed citations
8.
Park, Yujin, Jiyeon Son, Byung‐Mu Lee, Hyung Sik Kim, & Sungpil Yoon. (2017). Highly Eribulin-resistant KBV20C Oral Cancer Cells Can Be Sensitized by Co-treatment with the Third-generation P-Glycoprotein Inhibitor, Elacridar, at a Low Dose. Anticancer Research. 37(8). 4139–4146. 17 indexed citations
9.
Choi, Ae‐Ran, et al.. (2015). Co-treatment of Salinomycin Sensitizes AZD5363-treated Cancer Cells Through Increased Apoptosis.. PubMed. 35(9). 4741–7. 10 indexed citations
10.
Kim, Tae Hyung, Hyuk Soon Kim, Sungpil Yoon, et al.. (2014). Psammaplin A induces Sirtuin 1-dependent autophagic cell death in doxorubicin-resistant MCF-7/adr human breast cancer cells and xenografts. Biochimica et Biophysica Acta (BBA) - General Subjects. 1850(2). 401–410. 37 indexed citations
11.
Kim, Ju-Hwa, et al.. (2013). SP600125 overcomes antimitotic drug-resistance in cancer cells by increasing apoptosis with independence of P-gp inhibition. European Journal of Pharmacology. 723. 141–147. 20 indexed citations
12.
Lee, Young Ju, A Jin Won, Jaewon Lee, et al.. (2012). Molecular Mechanism of SAHA on Regulation of Autophagic Cell Death in Tamoxifen-Resistant MCF-7 Breast Cancer Cells. International Journal of Medical Sciences. 9(10). 881–893. 99 indexed citations
13.
Wang, Jing, Tae Hyung Kim, Mee Young Ahn, et al.. (2012). Sirtinol, a class III HDAC inhibitor, induces apoptotic and autophagic cell death in MCF-7 human breast cancer cells. International Journal of Oncology. 41(3). 1101–1109. 109 indexed citations
14.
Kim, Ju-Hwa, Tae Hyung Kim, Han Sung Kang, et al.. (2009). SP600125, an inhibitor of Jnk pathway, reduces viability of relatively resistant cancer cells to doxorubicin. Biochemical and Biophysical Research Communications. 387(3). 450–455. 27 indexed citations
15.
Yoon, Sungpil & Alan G. Hinnebusch. (2009). Mcm1p binding sites in ARG1 positively regulate Gcn4p binding and SWI/SNF recruitment. Biochemical and Biophysical Research Communications. 381(1). 123–128. 4 indexed citations
16.
Govind, Chhabi K., Sungpil Yoon, Hongfang Qiu, Sudha Govind, & Alan G. Hinnebusch. (2005). Simultaneous Recruitment of Coactivators by Gcn4p Stimulates Multiple Steps of Transcription In Vivo. Molecular and Cellular Biology. 25(13). 5626–5638. 91 indexed citations
17.
Yoon, Sungpil, et al.. (2004). Magnetic properties of a Mn12O12(O2CC4H3S)(16)(H2O)(4) single-molecule magnet. Journal of the Korean Physical Society. 45(6). 1593–1597. 5 indexed citations
18.
Yoon, Sungpil, Joo‐Heung Lee, & Seung‐Chul Lee. (2001). The Therapeutic Effect of Evening Primrose Oil in Atopic Dermatitis Patients with Dry Scaly Skin Lesions Is Associated with the Normalization of Serum Gamma-Interferon Levels. Skin Pharmacology and Physiology. 15(1). 20–25. 23 indexed citations
19.
Yoon, Sungpil, Gerard Tromp, Sompong Vongpunsawad, et al.. (1999). Genetic Analysis of MMP3, MMP9, and PAI-1 in Finnish Patients with Abdominal Aortic or Intracranial Aneurysms. Biochemical and Biophysical Research Communications. 265(2). 563–568. 99 indexed citations
20.
Yoon, Sungpil, et al.. (1997). Purification and Characterization of Protein Carboxyl O-Methyltransferase from Porcine Spleen. BMB Reports. 30(6). 410–414. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026